These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 22719186)

  • 1. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients.
    Liu XD; Wu JL; Liang J; Zhang T; Sheng QS
    World J Gastroenterol; 2012 Jun; 18(22):2784-92. PubMed ID: 22719186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus.
    Cao X; Shang QH; Chi XL; Zhang W; Xiao HM; Sun MM; Chen G; An Y; Lv CL; Wang L; Nan YM; Chen CY; Tan ZN; Liu XE; Zhuang H
    World J Gastroenterol; 2020 Mar; 26(10):1067-1079. PubMed ID: 32205997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
    World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic value of a globulin/platelet model for evaluating liver fibrosis in chronic hepatitis B patients.
    Coskun BD; Altinkaya E; Sevinc E; Ozen M; Karaman H; Karaman A; Poyrazoglu O
    Rev Esp Enferm Dig; 2015 Dec; 107(12):740-4. PubMed ID: 26671586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A noninvasive indicator for the diagnosis of early hepatitis B virus-related liver fibrosis.
    Li B; Zhang L; Zhang Z; Yan G; Zhu L; Lu W; Yu H
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):218-223. PubMed ID: 30277926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
    Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
    [No Abstract]   [Full Text] [Related]  

  • 7. [A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].
    Tu XL; Xiao YQ; Chen F
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):28-32. PubMed ID: 19203448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.
    Li Q; Lu C; Li W; Huang Y; Chen L
    Clin Exp Med; 2018 Feb; 18(1):71-78. PubMed ID: 28884309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q; Li W; Huang Y; Chen L
    J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.
    Zeng DW; Dong J; Jiang JJ; Zhu YY; Liu YR
    World J Gastroenterol; 2016 Nov; 22(43):9586-9594. PubMed ID: 27920479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
    Ucar F; Sezer S; Ginis Z; Ozturk G; Albayrak A; Basar O; Ekiz F; Coban S; Yuksel O; Armutcu F; Akbal E
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1076-81. PubMed ID: 23510962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection.
    Zhu X; Wang LC; Chen EQ; Chen XB; Chen LY; Liu L; Lei XZ; Liu C; Tang H
    Dig Dis Sci; 2011 Sep; 56(9):2742-9. PubMed ID: 21399926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AST-platelet ratio index in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B.
    Güzelbulut F; Sezıklı M; Akkan-Çetınkaya Z; Yaşar B; Özkara S; Kurdaş-Övünç AO
    Turk J Gastroenterol; 2012 Aug; 23(4):353-8. PubMed ID: 22965506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients.
    Kim BK; Kim DY; Park JY; Ahn SH; Chon CY; Kim JK; Paik YH; Lee KS; Park YN; Han KH
    Liver Int; 2010 Apr; 30(4):546-53. PubMed ID: 20074094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B.
    Noguchi R; Kaji K; Namisaki T; Moriya K; Kitade M; Takeda K; Kawaratani H; Okura Y; Aihara Y; Furukawa M; Mitoro A; Yoshiji H
    World J Gastroenterol; 2017 Sep; 23(36):6705-6714. PubMed ID: 29085215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
    Karagoz E; Ulcay A; Tanoglu A; Kara M; Turhan V; Erdem H; Oncul O; Gorenek L
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease.
    Zeng DW; Liu YR; Zhang JM; Zhu YY; Lin S; You J; Li YB; Chen J; Zheng Q; Jiang JJ; Dong J
    PLoS One; 2013; 8(10):e77942. PubMed ID: 24282481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients.
    Wang H; Xu H; Qu L; Wang X; Wu R; Gao X; Jin Q; Niu J
    Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):997-1002. PubMed ID: 27167453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients.
    Kang NL; Zhang JM; Lin MX; Chen XD; Huang ZX; Zhu YY; Liu YR; Zeng DW
    World J Gastroenterol; 2020 Jul; 26(27):3952-3962. PubMed ID: 32774069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of noninvasive tools for identification of minimal liver fibrosis in patients with hepatitis B virus infection.
    Zhang H; Shi X; Wang L; Zeng Y; Kang X; Huang L
    J Clin Lab Anal; 2021 Sep; 35(9):e23960. PubMed ID: 34403524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.